Qianyu Feng
Hongwei Zhao
Lili Xu
Zhengde Xie- 1Beijing Key Laboratory of Paediatric Respiratory Infection Diseases, Key Laboratory of Major Diseases in Children, National Key Discipline of Paediatrics (Capital Medical University), Ministry of Education, National Clinical Research Center for Respiratory Diseases, National Center for Children’s Health, Beijing Paediatric Research Institute, Beijing Children’s Hospital, Capital Medical University, Beijing, China
- 2Research Unit of Critical Infection in Children, Chinese Academy of Medical Sciences, Beijing, China
N6-methyladenosine (m6A) is a ubiquitous RNA modification in eukaryotes. It plays important roles in the translocation, stabilization and translation of mRNA. Many recent studies have shown that the dysregulation of m6A modification is connected with diseases caused by pathogenic viruses, and studies on the role of m6A in virus-host interactions have shown that m6A plays a wide range of regulatory roles in the life cycle of viruses. Respiratory viruses are common pathogens that can impose a large disease burden on young children and elderly people. Here, we review the effects of m6A modification on respiratory virus replication and life cycle and host immunity against viruses.
Introduction
RNA posttranscriptional modification is very common in eukaryotes, and more than one hundred types of modifications have been reported to date (Boccaletto et al., 2018). Most of these modifications are deposited on non-coding RNAs, such as ribosomal RNA (rRNA) and transfer RNA (tRNA), which play roles in regulating RNA structure, function, and translation (Cantara et al., 2010; Boccaletto et al., 2018). Among these modifications, m6A is the most common modification to poly(a) RNA components, and it is thought to be involved in the processing of messenger RNA (mRNA) (Desrosiers et al., 1974). The m6A modification involves a dynamically reversible process that is catalyzed by methyltransferases (writers) and eliminated by erasers. In addition, m6A can interact with m6A-binding protein (reader) or indirectly modulate the structure of RNA to regulate the interaction between RNA reader proteins (Jia et al., 2011; Liu et al., 2014; Ping et al., 2014). Recent evidence has shown that m6A participates in multiple stages of mRNA life, such as RNA folding and structure, maturation, stability, splicing, export, translation, and decay, and it plays an important role in these stages (Liu and Zhang, 2018).
In recent years, increasing numbers of studies have been conducted on the role of the m6A modification in different pathogenic viruses, with results revealing its impact on the regulation of the viral life cycle, such as its influence on the expression of specific genes related to the viral life cycle and its possible inhibition or promotion of the replication of various pathogenic viruses (Imam et al., 2020).
With the spread of all kinds of respiratory virus infections worldwide, respiratory virus infections have received increased attention. Respiratory virus infection can cause pneumonia in children, and severe cases can lead to acute respiratory distress syndrome, toxic encephalopathy, heart failure, etc., and in the elderly, it can aggravate underlying lung diseases and be life threatening. Respiratory viruses mainly include influenza virus, respiratory syncytial virus, and adenovirus. Influenza and respiratory syncytial virus cause nearly 300,000 deaths in children under 5 years old every year, while adenovirus and other viruses are associated with high morbidity and mortality rates (Nair et al., 2010; Wang et al., 2020). In particular, several emerging respiratory viruses with potentially epidemic characteristics, such as SARS-CoV-2, which causes coronavirus disease 2019 (COVID-19), threaten the world. The burden of disease caused by respiratory viruses has received increasing attention.
In this paper, the role of the m6A modification in the replication of respiratory viruses and its effect on the host immune response are discussed.
RNA m6A Modifications and Protein Factors
The m6A modification is regulated by methyltransferase, demethylase and m6A RNA-binding proteins. Methyltransferases play roles as “writers” and include methyltransferase-like 3 (METTL3), METTL14, and Wilm’s tumor-associated protein (WTAP). Among these proteins, METTL3 and METTL14 form heterodimers and promote intracellular mRNA methylation (Liu et al., 2014), but only METTL3 has methyltransferase activity, with METTL14 involved in substrate recognition (Śledź and Jinek, 2016; Wang P. et al., 2016; Wang X. et al., 2016). In addition, METTL14 can provide RNA-binding scaffolds, participate in allosteric activation and enhance the catalytic function of METTL3 (Śledź and Jinek, 2016). WTAP drives the m6A “writer” complex to the splice site by interacting with the METTL3/METTL14 heterodimer (Liu et al., 2014; Wu et al., 2016). Recently, two other members of the m6A methyltransferase complex, RBM15, and its homologous partner, RBM15b, have been shown to recruit the METTL3/METTL4 protein complex to target RNA for selective methylation (Patil et al., 2016).
Demethylation enzymes, including fat mass and obesity protein (FTO) and ALKB homologous 5 (ALKBH5), belong to the family of Fe2 + /alpha-ketoglutarate-dependent dioxygenases and play an “eraser” role in m6A methylation (Tan and Gao, 2018). FTO is located in the nucleus and cytoplasm (Jia et al., 2011; Cheung et al., 2013), and ALKBH5 is located in the nucleus (Zheng et al., 2013). FTO regulates the exon splicing of the adipogenic regulator RUNX1T1 by regulating the level of m6A near splice sites, thereby regulating differentiation (Zhao et al., 2014). The demethylation activity of ALKBH5 significantly affects mRNA output, RNA metabolism and mRNA processing factor assembly in nuclear speckles (Zheng et al., 2013).
The role of m6A RNA-binding protein is as a “reader.” The most well-known readers include the three members of the YTH domain family (YTHDF), YTHDF1, YTHDF2 and YTHDF3, located in the cytoplasm (Dominissini et al., 2012; Wang et al., 2015; Shi et al., 2017). In addition, two other readers are YTHDC proteins, in which YTHDC1 is located in the nucleus and YTHDC2 is located in the cytoplasm (Morohashi et al., 2011; Xu et al., 2014). YTHDF1 directly interacts with the translation initiation factor eukaryotic initiation factor 3 (eIF3) to increase the translation efficiency of mRNA targets (Wang et al., 2015), while YTHDF2 directly recruits the CCR4-NOT dehydrogenase complex to accelerate the degradation of m6A -modified RNA (Wang et al., 2014). Previous studies have shown that the N-terminal domain of YTHDF2 facilitates YTHDF2-mRNA complex localization in P-bodies, which are involved in mRNA degradation (Du et al., 2016). YTHDF3 promotes the functions of YTHDF1 and YTHDF2, cooperates with YTHDF1 to promote translation, and cooperates with YTHDF2 to promote mRNA activity attenuation (Li et al., 2017; Shi et al., 2017). YTHDC1 can drive the binding of methylated mRNA targets to serine and arginine rich splicing factor 3 (SRSF3) and nuclear export factor 1 (NXF1) to form mRNA-protein complexes (mRNPs), which together promote nuclear export of RNA (Roundtree et al., 2017). In addition, YTHDC1 is competitively bound by SRSF3 and SRSF10 to regulate RNA splicing (Xiao et al., 2016). YTHDC2 interacts with small ribosomal subunits and XRN1 to affect RNA translation and degradation, respectively (Hsu et al., 2017; Wojtas et al., 2017). In addition to members of the YTH family, other proteins have been reported to bind to m6A. The combination of an m6A-modified 5′UTR and eIF3 complex can directly recruit the 43S preinitiation complex to the 5′UTR of the mRNA, thereby stimulating translation initiation (Meyer et al., 2015). Splicing and microRNA maturation is regulated by the binding of hnRNPA2/B1 to m6A-modified RNA (Alarcón et al., 2015). Under normal and stress conditions, insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs) promote the stability and storage of their target mRNAs in an m6A-dependent manner, thereby affecting gene expression output (Huang et al., 2018).
The Role of m6A During Respiratory Virus Infections
m6A and Adenovirus
An adenovirus (AdV) is a DNA virus that relies on the processing of host RNA (Price et al., 2020). It uses cellular RNA polymerase II and spliceosome mechanisms to produce early and late genes from two DNA strands to produce mature mRNA (Sommer et al., 1976). Price et al. (2020) found that after adenovirus infection of A549 cells, the expression levels of other interacting enzymes did not change significantly, except for a slight increase in the levels of FTO and ALKBH5, and the host proteins were concentrated at the sites of early viral RNA synthesis. Through indirect immunofluorescence microscopy, it has been observed that some writer proteins, such as METTL3, METTL14, and WTAP, and reader protein YTHDC1 migrate from areas of dispersion in the nucleus to the site of viral RNA synthesis within 18 h of A549 cells infection with AdV5 (Price et al., 2020).
According to the research of Price, the early and late viral transcripts of adenovirus include METTL3-dependent m6A modifications, but m6A is not necessary for the early phase of adenovirus infection (Price et al., 2020). This group knocked out METTL3 or METTL14 and infected cells 48 h later, and the early gene replication and transcription products of the virus were found to be basically unaffected after infection, but the production of late RNA, late protein, and infectious progeny was significantly reduced in the METTL3- and METTL14-knockout cells (Price et al., 2020). Moreover, the cytoplasmic m6A reader and eraser did not affect the adenovirus infection cycle (Price et al., 2020).
The different effects of m6A deletion on early and late viral RNAs are mainly due to the important role that m6A plays in regulating the splicing efficiency of late viral RNA (Price et al., 2020). Spliced and unspliced viral RNA was detected by qRT-PCR, and the ratio of the two products was used to determine splicing efficiency (Price et al., 2020). After METTL3 or WTAP knockout, the splicing efficiency of the protein encoded by the E1A gene expressed early during infection did not change, while the splicing efficiency of the protein encoded by the fiber gene expressed late in infection decreased significantly (Price et al., 2020). Similar but much less dramatic results were observed upon YTHDC1 knockout (Price et al., 2020). Moreover, METTL3 knockout is widely downregulated during adenovirus late RNA processing. Short-read sequencing results showed that the overall abundance of all viral transcripts in late infection, except that of L152K, was reduced after METTL3 knockout (Price et al., 2020).
m6A and Respiratory Syncytial Virus
Human respiratory syncytial virus (RSV) is a non-segmented negative strand (NNS) RNA virus in which both genomic and anti-genomic mRNAs undergo m6A modification (Whelan et al., 2016). Xue et al. (2019) found that RSV replication was positively regulated by m6A reader and writer proteins, but eraser proteins had the opposite, negative regulatory, effect. RT-PCR was used to measure RSV genomic RNA and mRNA in cells. Although overexpression of YTHDF1-3 significantly increased the synthesis of RSV genomic RNA and mRNA, overexpression of YTHDF2 resulted in more active replication of RSV than transcription and more synthesized RNA than mRNA (Xue et al., 2019). When METTL3 and METTL14 were overexpressed in HeLa cells, increased synthesis of viral proteins was observed, and the level of m6A marks in viral RNA was significantly higher than that in control groups (Xue et al., 2019). In contrast, eraser proteins downregulated RSV replication and reduced viral RNA m6A content (Xue et al., 2019).
Abrogation of m6A was shown to result in attenuated RSV infection (Xue et al., 2019). Because m6A on the G gene and G mRNA is more abundantly enriched than other genes and mRNA, silent mutation of m6A sites in the modified region produced mutated RSV (rgRSVs) expressing recombinant green fluorescent protein (Xue et al., 2019). Compared with parental rgRSV, m6A-mutant rgRSVs showed inhibited viral protein synthesis, delayed replication kinetics, and reduced titers (Xue et al., 2019). In addition, in an in vivo model of lower respiratory tract infection HAE, replication and spread of m6A-site-mutated rgRSVs were defective, and the pathogenicity of these viruses was reduced (Xue et al., 2019). However, the immunogenicity of m6A-site-mutant rgRSVs was high in cotton mice (Xue et al., 2019).
m6A and Human Metapneumovirus
Human metapneumovirus (hMPV) is a NNS RNA virus. Lu et al. (2020) found that the hMPV genome, antigenome and mRNA all contain m6A modifications, and the strongest m6A peak appeared in the G gene of the genome and antigenome. The effect of m6A on hMPV is similar to that on RSV. According to Lu’s research, replication and gene expression of hMPV were promoted by m6A modification, and weakening of hMPV infection in cell culture was caused by the abolition of m6A (Lu et al., 2020). Both transient and stable overexpression of m6A-binding proteins had pro-viral effects in hMPV infection, and the replication, protein and RNA levels of hMPV were significantly upregulated by overexpression of writer proteins (Lu et al., 2020).
m6A and Influenza A Virus
The influenza A virus (IAV) genome consists of eight single-stranded negative-sense RNA segments that replicate in the nucleus (Noda et al., 2012). Courtney et al. (2017) found that the expression of IAV transcripts was prompted by cis-action of m6A-modified residues. When METTL3 was knocked out or the m6A site in IAV haemagglutinin (HA) was removed, a reduction in viral gene expression, replication and pathogenicity was observed (Courtney et al., 2017). In addition, the expression of the IAV gene and the production of virus particles were increased by the overexpression of YTHDF2, but overexpression of YTHDF1 and YTHDF3 had little effect on IAV replication (Courtney et al., 2017).
According to Courtney’s research, because the deposition of m6A not only enhanced splicing but also enhanced the expression of unspliced IAV gene fragments at equivalent levels; therefore, the m6A modification is unlikely regulate splicing (Courtney et al., 2017). In addition, the increase in IAV protein expression was closely related to an increase in mRNA expression; the m6A modification is also unlikely to enhance translation (Courtney et al., 2017). The mechanism by which the m6A modification increases IAV gene expression and viral replication needs to be further explored.
m6A and the Antiviral Response
m6A modification not only can affect virus replication but can also regulate the immune response of virus infection, but the influence of the m6A modification on the host immune response during virus infection has not been fully elucidated.
Viral RNA genomes and intermediates formed during viral replication often have uncapped RNAs with 5′-triphosphate or 5′-diphosphate groups, which can be detected by cytoplasmic RIG-I (McFadden and Horner, 2020). RIG-I binds non-self RNA and induces signal transduction through mitochondrial antiviral signaling proteins (MAVS) to produce type I and type III interferons (IFNs), thereby activating the antiviral response (McFadden and Horner, 2020). A study by Lu et al. showed that the detection of RNA 5′ triphosphorylation by RIG-I was diminished by the m6A modification of the NNS genome and antigenome, and three NNS RNA virus families (Pneumoviridae, Paramyxoviridae, and Rhabdoviridae) imitated host RNA through m6A modification to avoid RIG-I recognition (Lu et al., 2021). In another study by Lu, hMPV was used as a model to demonstrate that m6A acts as a molecular marker to distinguish self- from non-self RNA via RIG-I (Lu et al., 2020). When the viral antigenome and genomic RNA were deficient in m6A marks, enhanced activation of the RIG-I signaling pathway was observed (Lu et al., 2020). In contrast, the demethylase ALKBH5 was recruited by the RNA helicase DDX46 to demethylate m6A-modified antiviral transcripts, which were then retained in the nucleus, preventing their translation and inhibiting the production of interferon (Zheng et al., 2017).
Multiple studies have shown that METTL3-mediated methylation of viral RNA m6A promotes immune escape. Winkler et al. (2019) demonstrated that the loss of METTL3 led to increased induction of interferon-stimulated immune responses. In addition to METTL3 depletion, the deletion of METTL14 increased IFNB1 mRNA production and reduced viral replication (Rubio et al., 2018). In addition, YTHDF2 deletion led to increased type I interferon levels and greater induction of interferon-stimulated genes (Winkler et al., 2019). YTHDF2 was shown to isolate m6A-modified circular RNAs and prevent endogenous circular RNAs from activating the RIG-I antiviral pathway (Lu et al., 2020).
Demethylation of m6A viral RNA presents potential antiviral therapeutic opportunities. Methylase inhibitor 3-deazaadenosine (DAA) has an antiviral effect (Gordon et al., 2003; Kennedy et al., 2016; Manners et al., 2019), but because DAA reduces the formation of methyl donor S-adenosylmethionine (SAM) (Fustin et al., 2013) and thus inhibits all types of RNA modification, it is not clear which mechanism of methylation inhibition causes the antiviral effect. Therefore, the development of new drugs specifically targeting the mechanism by which m6A modification regulates viral infection will be important to the advancement of antiviral therapy.
Concluding Remarks
In this review, we discussed the latest developments in the role of m6A methylation in the life cycle of respiratory viruses. In AdV, RSV, hMPV, and IAV, m6A modification mainly supports virus replication (Table 1). However, in other viruses, such as ZIKV and HCV, m6A plays a negative regulatory role in virus replication (Manners et al., 2019). This disparity indicates that m6A has a complicated role in the process of viral gene expression.
Table 1. The regulators of m6A in respiratory viruses.
In addition, m6A modification is widely involved in the immune response, but the mechanism by which the m6A modification affects antiviral immunity is not fully understood. The role of m6A modification in the antiviral immune response needs to be further studied in the future, with the results expected to help in developing new antiviral treatment strategies.
Author Contributions
QF and HZ wrote the initial draft of the manuscript. ZX reviewed the manuscript. LX proposed the original idea and reviewed the manuscript. This work represents a collaboration among all of the authors. All authors read and approved the final submitted version of the manuscript.
Funding
This work was supported by grants from the National Major S&T Research Projects for the Control and Prevention of Major Infections Diseases in China (2017ZX10103004-004 and 2018ZX10305409-001-004) and the CAMS Innovation Fund for Medical Sciences (CIFMS, 2019-12M-5-026).
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
Alarcón, C. R., Goodarzi, H., Lee, H., Liu, X., Tavazoie, S., and Tavazoie, S. F. (2015). HNRNPA2B1 is a mediator of m6A-dependent nuclear RNA processing events. Cell 162, 1299–1308. doi: 10.1016/j.cell.2015.08.011
Boccaletto, P., Machnicka, M. A., Purta, E., Pia̧tkowski, P., Bagiñski, B., Wirecki, T. K., et al. (2018). MODOMICS: a database of RNA modification pathways. 2017 update. Nucleic Acids Res. 46, D303–D307.
Cantara, W. A., Crain, P. F., Rozenski, J., McCloskey, J. A., Harris, K. A., Zhang, X., et al. (2010). The RNA modification database. RNAMDB: 2011 update. Nucleic Acids Res. 39, D195–D201.
Cheung, M., Gulati, P., O’rahilly, S., and Yeo, G. (2013). FTO expression is regulated by availability of essential amino acids. Int. J. Obes. 37, 744–747. doi: 10.1038/ijo.2012.77
Courtney, D. G., Kennedy, E. M., Dumm, R. E., Bogerd, H. P., Tsai, K., Heaton, N. S., et al. (2017). Epitranscriptomic enhancement of influenza A virus gene expression and replication. Cell Host Microbe 22, 377–386. doi: 10.1016/j.chom.2017.08.004
Desrosiers, R., Friderici, K., and Rottman, F. (1974). Identification of methylated nucleosides in messenger RNA from Novikoff hepatoma cells. Proc. Natl. Acad. Sci. U.S.A. 71, 3971–3975. doi: 10.1073/pnas.71.10.3971
Dominissini, D., Moshitch-Moshkovitz, S., Schwartz, S., Salmon-Divon, M., Ungar, L., Osenberg, S., et al. (2012). Topology of the human and mouse m 6 A RNA methylomes revealed by m 6 A-seq. Nature 485, 201–206. doi: 10.1038/nature11112
Du, H., Zhao, Y., He, J., Zhang, Y., Xi, H., Liu, M., et al. (2016). YTHDF2 destabilizes m 6 A-containing RNA through direct recruitment of the CCR4–NOT deadenylase complex. Nat. Commun. 7:12626.
Fustin, J.-M., Doi, M., Yamaguchi, Y., Hida, H., Nishimura, S., Yoshida, M., et al. (2013). RNA-methylation-dependent RNA processing controls the speed of the circadian clock. Cell 155, 793–806. doi: 10.1016/j.cell.2013.10.026
Gordon, R. K., Ginalski, K., Rudnicki, W. R., Rychlewski, L., Pankaskie, M. C., Bujnicki, J. M., et al. (2003). Anti−HIV−1 activity of 3−deaza−adenosine analogs: inhibition of S−adenosylhomocysteine hydrolase and nucleotide congeners. Eur. J. Biochem. 270, 3507–3517. doi: 10.1046/j.1432-1033.2003.03726.x
Hsu, P. J., Zhu, Y., Ma, H., Guo, Y., Shi, X., Liu, Y., et al. (2017). Ythdc2 is an N 6-methyladenosine binding protein that regulates mammalian spermatogenesis. Cell Res. 27, 1115–1127. doi: 10.1038/cr.2017.99
Huang, H., Weng, H., Sun, W., Qin, X., Shi, H., Wu, H., et al. (2018). Recognition of RNA N 6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nat. Cell Biol. 20, 285–295. doi: 10.1038/s41556-018-0045-z
Imam, H., Kim, G.-W., and Siddiqui, A. (2020). Epitranscriptomic (N6-methyladenosine) modification of viral RNA and virus-host interactions. Front. Cell. Infect. Microbiol. 10:584283. doi: 10.3389/fcimb.2020.584283
Jia, G., Fu, Y., Zhao, X., Dai, Q., Zheng, G., Yang, Y., et al. (2011). N 6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat. Chem. Biol. 7, 885–887. doi: 10.1038/nchembio.687
Kennedy, E. M., Bogerd, H. P., Kornepati, A. V., Kang, D., Ghoshal, D., Marshall, J. B., et al. (2016). Posttranscriptional m6A editing of HIV-1 mRNAs enhances viral gene expression. Cell Host Microbe 19, 675–685. doi: 10.1016/j.chom.2016.04.002
Li, A., Chen, Y.-S., Ping, X.-L., Yang, X., Xiao, W., Yang, Y., et al. (2017). Cytoplasmic m 6 A reader YTHDF3 promotes mRNA translation. Cell Res. 27, 444–447. doi: 10.1038/cr.2017.10
Liu, J., Yue, Y., Han, D., Wang, X., Fu, Y., Zhang, L., et al. (2014). A METTL3–METTL14 complex mediates mammalian nuclear RNA N 6-adenosine methylation. Nat. Chem. Biol. 10, 93–95. doi: 10.1038/nchembio.1432
Liu, Z., and Zhang, J. (2018). Human C-to-U coding RNA editing is largely nonadaptive. Mol. Biol. Evol. 35, 963–969. doi: 10.1093/molbev/msy011
Lu, M., Xue, M., Wang, H.-T., Kairis, E. L., Ahmad, S., Wei, J., et al. (2021). Non-segmented negative-sense RNA viruses utilize N6-methyladenosine (m6A) as a common strategy to evade host innate immunity. J. Virol. 95:e01939-20.
Lu, M., Zhang, Z., Xue, M., Zhao, B. S., Harder, O., Li, A., et al. (2020). N 6-methyladenosine modification enables viral RNA to escape recognition by RNA sensor RIG-I. Nat. Microbiol. 5, 584–598. doi: 10.1038/s41564-019-0653-9
Manners, O., Baquero-Perez, B., and Whitehouse, A. (2019). m6A: widespread regulatory control in virus replication. Biochim. Biophys. Acta Gene Regul. Mech. 1862, 370–381. doi: 10.1016/j.bbagrm.2018.10.015
McFadden, M. J., and Horner, S. M. (2020). N6-methyladenosine regulates host responses to viral infection. Trends Biochem. Sci. 46, 366–367. doi: 10.1016/j.tibs.2020.11.008
Meyer, K. D., Patil, D. P., Zhou, J., Zinoviev, A., Skabkin, M. A., Elemento, O., et al. (2015). 5′ UTR m6A promotes cap-independent translation. Cell 163, 999–1010. doi: 10.1016/j.cell.2015.10.012
Morohashi, K., Sahara, H., Watashi, K., Iwabata, K., Sunoki, T., Kuramochi, K., et al. (2011). Cyclosporin A associated helicase-like protein facilitates the association of hepatitis C virus RNA polymerase with its cellular cyclophilin B. PLoS One 6:e18285. doi: 10.1371/journal.pone.0018285
Nair, H., Nokes, D. J., Gessner, B. D., Dherani, M., Madhi, S. A., Singleton, R. J., et al. (2010). Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 375, 1545–1555.
Noda, T., Sugita, Y., Aoyama, K., Hirase, A., Kawakami, E., Miyazawa, A., et al. (2012). Three-dimensional analysis of ribonucleoprotein complexes in influenza A virus. Nat. Commun. 3:639.
Patil, D. P., Chen, C.-K., Pickering, B. F., Chow, A., Jackson, C., Guttman, M., et al. (2016). m 6 A RNA methylation promotes XIST-mediated transcriptional repression. Nature 537, 369–373. doi: 10.1038/nature19342
Ping, X.-L., Sun, B.-F., Wang, L., Xiao, W., Yang, X., Wang, W.-J., et al. (2014). Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase. Cell Res. 24, 177–189. doi: 10.1038/cr.2014.3
Price, A. M., Hayer, K. E., McIntyre, A. B., Gokhale, N. S., Abebe, J. S., Della Fera, A. N., et al. (2020). Direct RNA sequencing reveals m 6 A modifications on adenovirus RNA are necessary for efficient splicing. Nat. Commun. 11:6016.
Roundtree, I. A., Luo, G.-Z., Zhang, Z., Wang, X., Zhou, T., Cui, Y., et al. (2017). YTHDC1 mediates nuclear export of N6-methyladenosine methylated mRNAs. eLife 6:e31311.
Rubio, R. M., Depledge, D. P., Bianco, C., Thompson, L., and Mohr, I. (2018). RNA m6 A modification enzymes shape innate responses to DNA by regulating interferon β. Genes Dev. 32, 1472–1484. doi: 10.1101/gad.319475.118
Shi, H., Wang, X., Lu, Z., Zhao, B. S., Ma, H., Hsu, P. J., et al. (2017). YTHDF3 facilitates translation and decay of N 6-methyladenosine-modified RNA. Cell Res. 27, 315–328. doi: 10.1038/cr.2017.15
Śledź, P., and Jinek, M. (2016). Structural insights into the molecular mechanism of the m6A writer complex. eLife 5:e18434.
Sommer, S., Salditt-Georgieff, M., Bachenheimer, S., Darnell, J., Furuichi, Y., Morgan, M., et al. (1976). The methylation of adenovirus-specific nuclear and cytoplasmic RNA. Nucleic Acids Res. 3, 749–766. doi: 10.1093/nar/3.3.749
Wang, P., Doxtader, K. A., and Nam, Y. (2016). Structural basis for cooperative function of Mettl3 and Mettl14 methyltransferases. Mol. Cell 63, 306–317. doi: 10.1016/j.molcel.2016.05.041
Wang, X., Feng, J., Xue, Y., Guan, Z., Zhang, D., Liu, Z., et al. (2016). Structural basis of N 6-adenosine methylation by the METTL3–METTL14 complex. Nature 534, 575–578. doi: 10.1038/nature18298
Wang, X., Li, Y., O’Brien, K. L., Madhi, S. A., Widdowson, M.-A., Byass, P., et al. (2020). Global burden of respiratory infections associated with seasonal influenza in children under 5 years in 2018: a systematic review and modelling study. Lancet Glob. Health 8, e497–e510.
Wang, X., Lu, Z., Gomez, A., Hon, G. C., Yue, Y., Han, D., et al. (2014). N 6-methyladenosine-dependent regulation of messenger RNA stability. Nature 505, 117–120. doi: 10.1038/nature12730
Wang, X., Zhao, B. S., Roundtree, I. A., Lu, Z., Han, D., Ma, H., et al. (2015). N6-methyladenosine modulates messenger RNA translation efficiency. Cell 161, 1388–1399. doi: 10.1016/j.cell.2015.05.014
Whelan, J. N., Reddy, K. D., Uversky, V. N., and Teng, M. N. (2016). Functional correlations of respiratory syncytial virus proteins to intrinsic disorder. Mol. Biosyst. 12, 1507–1526. doi: 10.1039/c6mb00122j
Winkler, R., Gillis, E., Lasman, L., Safra, M., Geula, S., Soyris, C., et al. (2019). m 6 A modification controls the innate immune response to infection by targeting type I interferons. Nat. Immunol. 20, 173–182. doi: 10.1038/s41590-018-0275-z
Wojtas, M. N., Pandey, R. R., Mendel, M., Homolka, D., Sachidanandam, R., and Pillai, R. S. (2017). Regulation of m6A transcripts by the 3′ 5′ RNA helicase YTHDC2 is essential for a successful meiotic program in the mammalian germline. Mol. Cell 68, 374.–387.
Wu, R., Jiang, D., Wang, Y., and Wang, X. (2016). N 6-methyladenosine (m 6 A) methylation in mRNA with a dynamic and reversible epigenetic modification. Mol. Biotechnol. 58, 450–459. doi: 10.1007/s12033-016-9947-9
Xiao, W., Adhikari, S., Dahal, U., Chen, Y.-S., Hao, Y.-J., Sun, B.-F., et al. (2016). Nuclear m6A reader YTHDC1 regulates mRNA splicing. Mol. Cell 61, 507–519.
Xu, C., Wang, X., Liu, K., Roundtree, I. A., Tempel, W., Li, Y., et al. (2014). Structural basis for selective binding of m 6 A RNA by the YTHDC1 YTH domain. Nat. Chem. Biol. 10, 927–929. doi: 10.1038/nchembio.1654
Xue, M., Zhao, B. S., Zhang, Z., Lu, M., Harder, O., Chen, P., et al. (2019). Viral N 6-methyladenosine upregulates replication and pathogenesis of human respiratory syncytial virus. Nat. Commun. 10:4595.
Zhao, X., Yang, Y., Sun, B.-F., Shi, Y., Yang, X., Xiao, W., et al. (2014). FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis. Cell Res. 24, 1403–1419. doi: 10.1038/cr.2014.151
Zheng, G., Dahl, J. A., Niu, Y., Fedorcsak, P., Huang, C.-M., Li, C. J., et al. (2013). ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. Mol. Cell 49, 18–29. doi: 10.1016/j.molcel.2012.10.015
Keywords: N6-methyladenosine, RNA modification, respiratory syncytial virus, adenovirus, human metapneumovirus, influenza A virus
Citation: Feng Q, Zhao H, Xu L and Xie Z (2021) N6-Methyladenosine Modification and Its Regulation of Respiratory Viruses. Front. Cell Dev. Biol. 9:699997. doi: 10.3389/fcell.2021.699997
Received: 25 April 2021; Accepted: 28 June 2021;
Published: 23 July 2021.
Edited by:
Xiao Han, Chinese Academy of Agricultural Sciences, ChinaReviewed by:
Lei Gu, Max Planck Institute for Heart and Lung Research, GermanyLei Sun, Shanghai Jiao Tong University, China
Jianmin Wang, Institute of Pathogen Biology (CAMS), China
Copyright © 2021 Feng, Zhao, Xu and Xie. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Lili Xu, anVzdGluZXh1bGwyNkAxNjMuY29t